In colorectal carcinoma, histone lactylation has been implicated in driving METTL3-mediated RNA m6A modification, promoting immune suppression in tumor-infiltrating myeloid cells and mediating tumor immune evasion 19. This evidence concerns the gene METTL3 and neoplasm.